je.st
news
Cobham Price Target Lowered to GBX 270 at JPMorgan Chase & Co.
2013-11-18 03:01:18| Biotech - Topix.net
The firm currently has a "neutral" rating on the stock. JPMorgan Chase & Co.' s price target points to a potential downside of 0.15% from the stock's previous close.
Tags: co
price
target
chase
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||